2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Infections are associated with most MS disease modifying therapies, but the risks and related management strategies vary considerably. Our faculty of MS neurologists and advanced practice providers will review 1) what therapies have what infection risks, including rare infection risks; 2) risk factors …
Track Archives:
Responding to the Needs of Individuals with Advanced MS: Integrated Approaches to Care, Function, and Quality of Life
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE People living with advanced multiple sclerosis (MS) experience increasing disability, complex symptom burden, and heightened risk of fragmentation or disengagement from care at a time when coordinated support is essential. With the field’s emphasis on disease modification and disability …
Botulinum Toxin Injections for Migraine and Spasticity in Multiple Sclerosis: A Hands-On Training Symposium
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This hands-on workshop is designed to transition participants from theoretical knowledge to clinical application, covering both upper and lower extremities. • Didactic Sessions: Participants will learn the mechanisms of action, therapeutic indications for MS-related spasticity, goal setting (e.g., using Goal Attainment Scaling), and patient …
The June Halper Memorial Lecture: The Journey is the Destination: 40 Years of CMSC, 40 Years of MS Neuropsychiatry
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Since the Consortium of MS Centers was founded, there have been considerable advances in the neuropsychiatry of multiple sclerosis. Forty years back, the prevalence of cognitive or depressive disorders associated with MS was unknown. Neuropsychiatric changes in MS were …
Turning the Tide on MS: Prodrome and Prevention Organized by the VA MSCoE
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This clinical course will present the current understanding of the MS prodrome. The MS prodrome will be contrasted with other neurological conditions. The diagnosis of the radiologically isolated syndrome and clinical management will be highlighted. Using data from population-based studies, risk factors for MS …
Continue reading “Turning the Tide on MS: Prodrome and Prevention Organized by the VA MSCoE”
Era of Too Many Choices; Starting and Switching
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE There has been an explosion of new MS disease modifying therapies over the last decade. These therapies offer people with MS many treatment options including different routes of administration and mechanisms of action. With so many treatment options, selecting the right therapy for …
Continue reading “Era of Too Many Choices; Starting and Switching”
Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 1
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …
Spinal Cord in MS: Key Clinical and Imaging Considerations
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Spinal cord disease is important in most people with MS , but is less emphasized in patient care, basic, clinical research, and therapeutic trials. Clinically relevant spinal cord disease in MS is crucial to recognize. How and when to image the spinal cord …
Continue reading “Spinal Cord in MS: Key Clinical and Imaging Considerations”
Making the Invisible Visible
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Invisible symptoms of multiple sclerosis (MS), including fatigue, cognitive/mood impairment, and sensory disturbances, are major contributors to functional decline and diminished quality of life (QoL), yet remain understudied, underrecognized, and undertreated in people with MS. In this session, we …